跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOFRAN ondansetron (as hydrochloride dihydrate) 4 mg/2 mL injection sterile syringe - TGA Drug Approval Details
Approvals
/
TGA
/
ZOFRAN ondansetron (as hydrochloride dihydrate) 4 mg/2 mL injection sterile syringe
Approved
STANDARD
ZOFRAN ondansetron (as hydrochloride dihydrate) 4 mg/2 mL injection sterile syringe
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
902e62ac9b1c6042
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
902e62ac9b1c6042
Product Name
ZOFRAN ondansetron (as hydrochloride dihydrate) 4 mg/2 mL injection sterile syringe
Artg Id
122091
Artg Name
ZOFRAN ondansetron (as hydrochloride dihydrate) 4 mg/2 mL injection sterile syringe
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
2006-02-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/d0e9b8a72d954f6db805b1dbc4ef57e2.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
902e62ac9b1c6042
Type
Standard
Back to TGA Approvals